{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:24:12Z","timestamp":1793255052243,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hyperparathyroidism (HPT) is a potential risk factor for graft loss after kidney transplantation (KTx). However, the effects of HPT management on graft outcomes remain unclear. This retrospective study aimed to investigate the impact of HPT status and its management on graft outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients who underwent KTx were categorized based on their HPT status and treatment at 1-year post-KTx into four groups: normal (no HPT), normocalcemic HPT, hypercalcemic HPT, or intervention (parathyroidectomy or calcimimetics within 1\u00a0year after KTx). Patients treated for HPT beyond the first year post-KTx were censored. The primary outcome was death-censored graft survival and the secondary outcome was the progression of interstitial fibrosis and tubular atrophy (IFTA) at 1-year post KTx.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 1264 patients, the 10-year death-censored graft-survival rate was lowest in the hypercalcemic HPT group (79.7%), whereas the intervention group had a survival rate of 100.0%. In the multivariate Cox regression analysis, hypercalcemic HPT was associated with an increased risk of graft loss (fully adjusted hazard ratio [HR]\u2009=\u20094.25,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001, compared to the normal group). Contrarily, the intervention group did not show an increased risk of graft loss (fully adjusted HR\u2009=\u20090.28,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.239). Additionally, hypercalcemia during the first year after KTx was significantly associated with IFTA progression (fully adjusted odds ratio\u2009=\u20091.91,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.038).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Hypercalcemic HPT was associated with inferior graft survival and IFTA progression. Proactive management of HPT may reduce the risk of graft loss and mitigate IFTA progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10157-025-02723-7","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T06:29:55Z","timestamp":1751610595000},"page":"1881-1891","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Post-transplantation management of hyperparathyroidism and its association with kidney graft survival and fibrosis"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8446-7841","authenticated-orcid":false,"given":"Manabu","family":"Okada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuhiko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Himeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Shimamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Futamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Hiramitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Narumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asami","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Ichimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Watarai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"issue":"8","key":"2723_CR1","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","volume":"15","author":"GA Block","year":"2004","unstructured":"Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15(8):2208\u201318.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2723_CR2","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.transproceed.2015.12.120","volume":"48","author":"HH Lee","year":"2016","unstructured":"Lee HH, Kim AJ, Ro H, Jung JY, Chang JH, Chung W, et al. Sequential changes of vitamin D level and parathyroid hormone after kidney transplantation. Transplant Proc. 2016;48(3):897\u20139.","journal-title":"Transplant Proc"},{"issue":"2","key":"2723_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/TP.0000000000000583","volume":"99","author":"H Pihlstr\u00f8m","year":"2015","unstructured":"Pihlstr\u00f8m H, Dahle DO, Mj\u00f8en G, Pilz S, M\u00e4rz W, Abedini S, et al. Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism. Transplantation. 2015;99(2):351\u20139.","journal-title":"Transplantation"},{"issue":"4","key":"2723_CR4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/SLA.0000000000001431","volume":"262","author":"I Lou","year":"2015","unstructured":"Lou I, Foley D, Odorico SK, Leverson G, Schneider DF, Sippel R, et al. How well does renal transplantation cure hyperparathyroidism? Ann Surg. 2015;262(4):653\u20139.","journal-title":"Ann Surg"},{"issue":"5","key":"2723_CR5","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.surg.2017.12.010","volume":"163","author":"M Araujo","year":"2018","unstructured":"Araujo M, Ramalho JAM, Elias RM, Jorgetti V, Nahas W, Custodio M, et al. Persistent hyperparathyroidism as a risk factor for long-term graft failure: the need to discuss indication for parathyroidectomy. Surgery. 2018;163(5):1144\u201350.","journal-title":"Surgery"},{"issue":"3","key":"2723_CR6","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1097\/SLA.0000000000005522","volume":"276","author":"S Dream","year":"2022","unstructured":"Dream S, Kuo LE, Kuo JH, Sprague SM, Nwariaku FE, Wolf M, et al. The American association of endocrine surgeons guidelines for the definitive surgical management of secondary and tertiary renal hyperparathyroidism. Ann Surg. 2022;276(3):e141\u201376.","journal-title":"Ann Surg"},{"issue":"3","key":"2723_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/1744-9987.12058","volume":"17","author":"M Fukagawa","year":"2013","unstructured":"Fukagawa M, Yokoyama K, Koiwa F, Taniguchi M, Shoji T, Kazama JJ, et al. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial. 2013;17(3):247\u201388.","journal-title":"Ther Apher Dial"},{"issue":"12","key":"2723_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167929","volume":"11","author":"L Berchtold","year":"2016","unstructured":"Berchtold L, Ponte B, Moll S, Hadaya K, Seyde O, Bachtler M, et al. Phosphocalcic markers and calcification propensity for assessment of interstitial fibrosis and vascular lesions in kidney allograft recipients. PLoS ONE. 2016;11(12): e0167929. https:\/\/doi.org\/10.1371\/journal.pone.0167929.","journal-title":"PLoS ONE"},{"issue":"1","key":"2723_CR9","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3390\/ijms22010408","volume":"22","author":"S Panizo","year":"2021","unstructured":"Panizo S, Mart\u00ednez-Arias L, Alonso-Montes C, Cannata P, Mart\u00edn-Carro B, Fern\u00e1ndez-Mart\u00edn JL, et al. Fibrosis in chronic kidney disease: pathogenesis and consequences. Int J Mol Sci. 2021;22(1):408.","journal-title":"Int J Mol Sci."},{"issue":"10","key":"2723_CR10","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1097\/TP.0000000000003678","volume":"105","author":"T Saritas","year":"2021","unstructured":"Saritas T, Kramann R. Kidney allograft fibrosis: diagnostic and therapeutic strategies. Transplantation. 2021;105(10):e114\u201330.","journal-title":"Transplantation"},{"issue":"11","key":"2723_CR11","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s40618-019-01075-w","volume":"42","author":"N Yalla","year":"2019","unstructured":"Yalla N, Bobba G, Guo G, Stankiewicz A, Ostlund R. Parathyroid hormone reference ranges in healthy individuals classified by vitamin D status. J Endocrinol Invest. 2019;42(11):1353\u201360.","journal-title":"J Endocrinol Invest"},{"issue":"5893","key":"2723_CR12","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1136\/bmj.4.5893.643","volume":"4","author":"RB Payne","year":"1973","unstructured":"Payne RB, Little AJ, Williams RB, Milner JR. Interpretation of serum calcium in patients with abnormal serum proteins. Br Med J. 1973;4(5893):643\u20136.","journal-title":"Br Med J"},{"issue":"6","key":"2723_CR13","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982\u201392.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"2723_CR14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10157-024-02497-4","volume":"28","author":"Japanese Society of Nephrology","year":"2024","unstructured":"Japanese Society of Nephrology. Essential points from evidence-based clinical practice guideline for chronic kidney disease 2023. Clin Exp Nephrol. 2024;28(6):473\u201395.","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"2723_CR15","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant. 2013;48(3):452\u20138.","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"2723_CR16","doi-asserted-by":"publisher","first-page":"e467","DOI":"10.1093\/oncolo\/oyad314","volume":"29","author":"R Wang","year":"2024","unstructured":"Wang R, Reed RD, Price G, Abraham P, Lewis M, McMullin JL, et al. Treatment of hypercalcemic hyperparathyroidism after kidney transplantation is associated with improved allograft survival. Oncologist. 2024;29(4):e467\u201374.","journal-title":"Oncologist"},{"issue":"2","key":"2723_CR17","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1097\/TP.0000000000003012","volume":"104","author":"E Van Loon","year":"2020","unstructured":"Van Loon E, Bernards J, Van Craenenbroeck AH, Naesens M. The causes of kidney allograft failure: more than alloimmunity. Viewp Article Transplant. 2020;104(2):e46\u201356.","journal-title":"Viewp Article Transplant."},{"issue":"9","key":"2723_CR18","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1111\/ajt.12369","volume":"13","author":"Y Ohashi","year":"2013","unstructured":"Ohashi Y, Thomas G, Nurko S, Stephany B, Fatica R, Chiesa A, et al. Association of metabolic syndrome with kidney function and histology in living kidney donors. Am J Transplant. 2013;13(9):2342\u201351.","journal-title":"Am J Transplant"},{"issue":"5","key":"2723_CR19","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1053\/j.ajkd.2009.01.255","volume":"53","author":"MP Alexander","year":"2009","unstructured":"Alexander MP, Patel TV, Farag YM, Florez A, Rennke HG, Singh AK. Kidney pathological changes in metabolic syndrome: a cross-sectional study. Am J Kidney Dis. 2009;53(5):751\u20139.","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"2723_CR20","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1111\/ajt.14292","volume":"17","author":"BJ Nankivell","year":"2017","unstructured":"Nankivell BJ, Renthawa J, Sharma RN, Kable K, O\u2019Connell PJ, Chapman JR. BK virus nephropathy: histological evolution by sequential pathology. Am J Transplant. 2017;17(8):2065\u201377.","journal-title":"Am J Transplant"},{"issue":"3","key":"2723_CR21","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1600-6143.2009.02966.x","volume":"10","author":"RL Heilman","year":"2010","unstructured":"Heilman RL, Devarapalli Y, Chakkera HA, Mekeel KL, Moss AA, Mulligan DC, et al. Impact of subclinical inflammation on the development of interstitial fibrosis and tubular atrophy in kidney transplant recipients. Am J Transplant. 2010;10(3):563\u201370.","journal-title":"Am J Transplant"},{"issue":"6","key":"2723_CR22","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1046\/j.1523-1755.2000.00419.x","volume":"58","author":"JT Norman","year":"2000","unstructured":"Norman JT, Clark IM, Garcia PL. Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int. 2000;58(6):2351\u201366.","journal-title":"Kidney Int"},{"issue":"6","key":"2723_CR23","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00467-018-3940-4","volume":"34","author":"GR Situmorang","year":"2019","unstructured":"Situmorang GR, Sheerin NS. Ischaemia reperfusion injury: mechanisms of progression to chronic graft dysfunction. Pediatr Nephrol. 2019;34(6):951\u201363.","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"2723_CR24","first-page":"175","volume":"30","author":"A Saad","year":"2015","unstructured":"Saad A, Herrmann SM, Textor SC. Chronic renal ischemia in humans: can cell therapy repair the kidney in occlusive renovascular disease? Physiology (Bethesda). 2015;30(3):175\u201382.","journal-title":"Physiology (Bethesda)"},{"issue":"1","key":"2723_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/TP.0b013e3181ff4f7f","volume":"91","author":"Y Miura","year":"2011","unstructured":"Miura Y, Satoh S, Saito M, Numakura K, Inoue T, Obara T, et al. Factors increasing quantitative interstitial fibrosis from 0 hr to 1 year in living kidney transplant patients receiving tacrolimus. Transplantation. 2011;91(1):78\u201385.","journal-title":"Transplantation"},{"issue":"4","key":"2723_CR26","doi-asserted-by":"publisher","first-page":"F880","DOI":"10.1152\/ajprenal.00195.2016","volume":"315","author":"MDP Sosa Pe\u00f1a","year":"2018","unstructured":"Sosa Pe\u00f1a MDP, Lopez-Soler R, Melendez JA. Senescence in chronic allograft nephropathy. Am J Physiol Renal Physiol. 2018;315(4):F880\u20139.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"12","key":"2723_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000001375","volume":"8","author":"G Ouellet","year":"2022","unstructured":"Ouellet G, Houde I, Riopel J, Latulippe E, Douville P, Lesage J, et al. The progression of interstitial fibrosis and tubular atrophy at 6 months is an independent predictor of poor graft outcomes in kidney transplant recipients. Transplant Direct. 2022;8(12): e1375.","journal-title":"Transplant Direct"},{"issue":"4","key":"2723_CR28","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/cvr\/cvy023","volume":"114","author":"RM Touyz","year":"2018","unstructured":"Touyz RM, Alves-Lopes R, Rios FJ, Camargo LL, Anagnostopoulou A, Arner A, et al. Vascular smooth muscle contraction in hypertension. Cardiovasc Res. 2018;114(4):529\u201339.","journal-title":"Cardiovasc Res"},{"issue":"12","key":"2723_CR29","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1111\/j.1432-2277.2012.01564.x","volume":"25","author":"HJ Jeon","year":"2012","unstructured":"Jeon HJ, Kim YJ, Kwon HY, Koo TY, Baek SH, Kim HJ, et al. Impact of parathyroidectomy on allograft outcomes in kidney transplantation. Transpl Int. 2012;25(12):1248\u201356.","journal-title":"Transpl Int"},{"issue":"8","key":"2723_CR30","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1093\/ndt\/gfm270","volume":"22","author":"AE Kruse","year":"2007","unstructured":"Kruse AE, Eisenberger U, Frey FJ, Mohaupt MG. Effect of cinacalcet cessation in renal transplant recipients with persistent hyperparathyroidism. Nephrol Dial Transplant. 2007;22(8):2362\u20135.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"2723_CR31","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.surg.2017.10.016","volume":"163","author":"SA Littbarski","year":"2018","unstructured":"Littbarski SA, Kaltenborn A, Gwiasda J, Beneke J, Arelin V, Schwager Y, et al. Timing of parathyroidectomy in kidney transplant candidates with secondary hyperparathryroidism: effect of pretransplant versus early or late post-transplant parathyroidectomy. Surgery. 2018;163(2):373\u201380.","journal-title":"Surgery"},{"issue":"3","key":"2723_CR32","first-page":"727","volume":"170","author":"S Frey","year":"2021","unstructured":"Frey S, Goronflot T, Kerleau C, Gourraud PA, Caillard C, Hourmant M, et al. Parathyroidectomy or cinacalcet: do we still not know the best option for graft function in kidney-transplanted patients? A Meta-Anal Surg. 2021;170(3):727\u201335.","journal-title":"A Meta-Anal Surg"},{"issue":"6","key":"2723_CR33","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.surg.2010.09.009","volume":"148","author":"R Schneider","year":"2010","unstructured":"Schneider R, Kolios G, Koch BM, Fern\u00e1ndez ED, Bartsch DK, Schlosser K. An economic comparison of surgical and medical therapy in patients with secondary hyperparathyroidism\u2013the German perspective. Surgery. 2010;148(6):1091\u20139.","journal-title":"Surgery"},{"issue":"7","key":"2723_CR34","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1097\/TP.0b013e318186b7fb","volume":"86","author":"KA Borchhardt","year":"2008","unstructured":"Borchhardt KA, Heinzl H, Mayerw\u00f6ger E, H\u00f6rl WH, Haas M, Sunder-Plassmann G. Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation. Transplantation. 2008;86(7):919\u201324.","journal-title":"Transplantation"},{"issue":"8","key":"2723_CR35","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1681\/ASN.2015060622","volume":"27","author":"JM Cruzado","year":"2016","unstructured":"Cruzado JM, Moreno P, Torregrosa JV, Taco O, Mast R, G\u00f3mez-Vaquero C, et al. A randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism. J Am Soc Nephrol. 2016;27(8):2487\u201394.","journal-title":"J Am Soc Nephrol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02723-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-025-02723-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02723-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T09:30:08Z","timestamp":1764235808000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-025-02723-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2723"],"URL":"https:\/\/doi.org\/10.1007\/s10157-025-02723-7","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Review Board (IRB) of the Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital (IRB approval number: 1636) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"An informed consent waiver was obtained from the IRB of Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital. Details regarding the study and its opt-outs are provided in detail on our institutional website.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}